From the Publisher of:

    Supported By:


Featured Articles: Vol. 3, Issue 1
Vol. 3, Issue 1

The data-reporting requirements for HIV clinics continue to grow. The specific demands from funding sources, particularly federal money provided through the Ryan White HIV/AIDS Treatment Extension Act of 2009, require an uncommon level of compliance.1 

Vol. 3, Issue 1

Living with HIV is a constant challenge, and providers caring for patients with the disease play a key role in helping their patients meet that challenge. 

Vol. 3, Issue 1

ID Advisor - Vol. 3, Issue 1

Vol. 3, Issue 1

The Hopkins AIDS Care Program began in January 1984 with the opening of the Moore Clinic for patients with HIV infection. It has since developed into a full-service care network.1 

Vol. 3, Issue 1

Several years ago, a patient with HIV arrived at the infectious disease program at Grady Health System in Atlanta, Georgia, with a bottle of pills covered in soot. A nurse jokingly asked, “Where are you keeping this, the fireplace?” The patient responded, “How did you guess?” Fearing stigma and discrimination, the woman was hiding her pills in order to keep her HIV status a secret.

Vol. 3, Issue 1

The VERxVE trial is an ongoing, multinational, Phase 3, double-blind, double-dummy, parallel-group, active-controlled trial with stratified randomization.1 It is being conducted at 175 centers in 20 countries around the world.2